Issued Patents 2023
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11814367 | Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof | David J. Morgans, Jr., Kevin T. Mellem, Hannah Powers, Patrick Lee, Christopher Joseph Sinz | 2023-11-14 |
| 11739093 | Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors | Brian R. BLANK, Jennifer Pitzen, Gang Wang, Christos TZITZILONIS, Jie Li +8 more | 2023-08-29 |
| 11702411 | Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors | Jie Li, Elena S. Koltun, Adrian Liam Gill, Andreas BUCKL, Naing Aay +4 more | 2023-07-18 |
| 11685749 | C26-linked rapamycin analogs as mTOR inhibitors | Christopher Semko, Gang Wang, G. Leslie Burnett, James Aggen, Gert Kiss +6 more | 2023-06-27 |
| 11673901 | Polycyclic compounds as allosteric SHP2 inhibitors | Elena S. Koltun, Naing Aay, Andreas BUCKL, Kevin T. Mellem, Brian R. BLANK +7 more | 2023-06-13 |
| 11661401 | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors | Elena S. Koltun, Kevin T. Mellem, Adrian Liam Gill, Gert Kiss, Christopher Semko +3 more | 2023-05-30 |